TrianglePUBLICATIONS · 38190578
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Apr 1
- First author
- Moreno L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Moreno L
- type
- Author
- name
- Weston R
- type
- Author
- name
- Owens C
- type
- Author
- name
- Valteau-Couanet D
- type
- Author
- name
- Gambart M
- type
- Author
- name
- Castel V
- type
- Author
- name
- Zwaan CM
- type
- Author
- name
- Nysom K
- type
- Author
- name
- Gerber N
- type
- Author
- name
- Castellano A
- type
- Author
- name
- Laureys G
- type
- Author
- name
- Ladenstein R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Moreno L
- type
- Author
- name
- Weston R
- type
- Author
- name
- Owens C
- type
- Author
- name
- Valteau-Couanet D
- type
- Author
- name
- Gambart M
- type
- Author
- name
- Castel V
- type
- Author
- name
- Zwaan CM
- type
- Author
- name
- Nysom K
- type
- Author
- name
- Gerber N
- type
- Author
- name
- Castellano A
- type
- Author
- name
- Laureys G
- type
- Author
- name
- Ladenstein R
- type
- Author
- bibliography ids
- nci-bib-77624b7270a0bc42dd0434ed
- book metadata
- content sha256
- 202701af4ce6ea7bca48568f2cc4d0c896403a86e23222018f12985df0722fd4
- document type
- citation
- dois
- 10.1200/JCO.23.00458
- electronic publication date
- display
- 2024 Jan 8
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38190578
- immutable id
- pubmed:38190578@202701af4ce6ea7bca48568f2cc4d0c896403a86e23222018f12985df0722fd4
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 10
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1135-1145
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38190578
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- d5a6b8cfaa4787585866b0fb30657bad2896ddc582571a8e39cda84fef01026a
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 Apr 1
- precision
- day
- year
- 2024
- publication types
- Randomized Controlled Trial
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
Preserved source evidence · Not medical advice